Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis Global Blood Plasma Market. The report analyses the Blood Plasma Market By Type (Immunoglobulins- IV+SC, Albumin, Factor VIII- Plasma Derived, and Others), By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S, Canada, Germany, France, Italy, China, Japan, India, Australia, and South-East Asia). The report on Blood Plasma assesses the market for the actual period of 2013-2017 and the forecast period of 2018-2023.

According to Azoth Analytics research report "Global Blood Plasma Market - Analysis By Type (Immunoglobulins - IV+SC, Albumin, Factor VIII - Plasma Derived), By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)", the global blood plasma market is projected to display a robust growth represented by a CAGR of 10.18% during 2018 - 2023.

The Blood Plasma market witness a substantial growth at a noteworthy rate over the past few years and anticipated to grow on the back of its increasing usage in plasma-derived medical products. In addition, rise in awareness towards plasma donation, rise of China blood plasma industry, introduction of new and specialized products, rising geriatric population, rapid increase of the healthcare expenditure on the diseases such as immunodeficiency, neurological disorders, clotting disabilities etc. anticipated to boost the market growth in future. Amongst the regions, North America accounts for the largest regional share in the global blood plasma market. Key factor driving the robust growth rate in North America region is collection of source plasma in large volume for the fractionation process.

The report titled "Global Blood Plasma Market - Analysis By Type (Immunoglobulins - IV+SC, Albumin, Factor VIII - Plasma Derived), By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)" has covered and analysed the potential of Global Blood Plasma Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global blood ingredients market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Blood Plasma Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Blood Plasma Market - Size, Growth, Forecast
• Analysis By Type- Size, Volume, Growth, Forecast
o Immunoglobulin (IV+SC)
o Albumin
o Factor VIII (Plasma Derived)

Regional Markets - North America, Europe, Asia Pacific, and Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Blood Plasma Market - Size, Growth, Forecast
• Analysis By Type
o Immunoglobulin (IV+SC)
o Albumin
o Factor VIII (Plasma Derived)

Country Analysis - U.S., Canada, Germany, France, Italy, China, Japan, India, Australia, and South-East Asia. (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Blood Plasma Market - Size, Growth, Forecast
• Analysis By Type
o Immunoglobulin (IV+SC)
o Albumin
o Factor VIII (Plasma Derived)

Other Report Highlights
• Market Dynamics - Drivers and Restraints
• Market Trends
• Porter Five Forces Analysis
• Company Analysis - CSL Limited, Baxter International, Grifols S.A, Octa Pharma, Emergent Bio-solutions, Antaris Pharma, AMAG Pharma, Biota Pharma, Bio delivery Science International, Biotest A.G.

Customization of the Report
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.

Table of contents 1. Research Methodology 2. Executive Summary 3. Strategic Recommendations 4. Global Blood Plasma Market: Product Outlook 5. Global Blood Plasma Market: Growth and Forecast 5.1 By Value (2013-2017) 5.2 By Value (2018-2023) 5.3 By Company Share (2017) 6. Global Blood Plasma Market Size, By Type: Breakdown (%) 6.1 Global Immunoglobulins (IV+SC) Market 6.1.1 By Value (2013-2023) 6.1.2 By Volume (2013-2023) 6.1.3 By Company Share, 2017 6.2 Global Albumin Market 6.2.1By Value (2013-2023) 6.2.2 By Volume (2013-2023) 6.2.3 By Company Share, 2017 6.3 Global FVIII (pd) Market 6.3.1 By Value (2013-2023) 6.3.2 By Volume (2013-2023) 6.3.3 By Company Share, 2017 6.4 Global Other Plasma Product Market: By Value (2013-2023) 6.5 Global Blood Plasma Market: Market Comparison, By Segments 6.6 Global Blood Plasma Market: Market Attractiveness, By Segments 7. Global Blood Plasma Market: Regional Analysis 7.1 North America Blood Plasma Market: An Analysis 7.1.1 By Value (2013-2017) 7.1.2 By Value (2018-2023) 7.2 North America Blood Plasma Market: Country Analysis 7.2.1 U.S.A Blood Plasma Market, By Value (2013-2023) 7.2.2 Canada Blood Plasma Market, By Value (2013-2023) 7.3 Europe Blood Plasma Market: An Analysis 7.3.1 By Value (2013-2017) 7.3.2 By Value (2018-2023) 7.4 Europe Blood Plasma Market: Country Analysis 7.4.1 Germany Blood Plasma Market, By Value (2013-2023) 7.4.2 France Blood Plasma Market, By Value (2013-2023) 7.4.3 Italy Blood Plasma Market, By Value (2013-2023) 7.5 APAC Blood Plasma Market: An Analysis 7.5.1 China Blood Plasma Market, By Value (2013-2023) 7.5.2 Japan Blood Plasma Market, By Value (2013-2023) 7.5.3 India Blood Plasma Market, By Value (2013-2023) 7.5.4 Australia Blood Plasma Market, By Value (2013-2023) 7.5.5 South-East Asia Blood Plasma Market, By Value (2013-2023) 7.6 ROW Blood Plasma Market: An Analysis 7.6.1 By Value (2013-2017) 7.6.2 By Value (2013-2023) 7.7 Global Blood Plasma Market: Market Comparison, By Regions 7.8 Global Blood Plasma Market: Market Attractiveness, By Regions 8. Global Blood Plasma Market Dynamics 8.1 Drivers 8.2 Challenges 8.3 Trends 9. Blood Plasma Market: Policy and Regulatory Landscape 10. Global Blood Plasma Market: Supply Chain Analysis 11. Porter's Five Forces Analysis 12 Company Profiles 12.1 CSL Limited 12.2 Baxter International 12.3 Grifols S.A. 12.4 Octa Pharma 12.5 Emergent Bio-solutions 12.6 Antaris Pharma 12.7 AMAG Pharma 12.8 Kedrion Biota Pharma 12.9 Bio delivery Science International 12.10 Biotest A.G.

Blood Relationship Testing Service Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Blood Relationship Testing Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...

Plasma-derived Therapies Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Plasma-derived Therapies Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactur...

Plasma Fractionation Technology Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Plasma Fractionation Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...

Blood Bank Information System Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Blood Bank Information System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manuf...

Asia Pacific Vital Sign Monitoring Devices Market Size, Share, Trends & Analysis by Product (Pulse Oximeters, Blood Pressure Monitors, Temperature Monitoring Devices, Glucose Monitoring Devices), by End User (Hospitals and Clinics, Ambulatory Care Centers, Home Healthcare, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Vital Sign Monitoring Devices Market is set to experience significant expansion from 2024 to 2034. This growth is driven by the increasing prevalence of chronic diseases, rising health awareness, and advancements in monitoring technology. The market is p...

Europe Vital Sign Monitoring Devices Market Size, Share, Trends & Analysis by Product (Pulse Oximeters, Blood Pressure Monitors, Temperature Monitoring Devices, Glucose Monitoring Devices), by End User (Hospitals and Clinics, Ambulatory Care Centers, Home Healthcare, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Vital Sign Monitoring Devices Market is projected to witness significant growth from 2024 to 2034, driven by increasing demand for continuous health monitoring, rising prevalence of chronic diseases, and the expanding elderly population. The market is anticipa...

North America Vital Sign Monitoring Devices Market Size, Share, Trends & Analysis by Product (Pulse Oximeters, Blood Pressure Monitors, Temperature Monitoring Devices, Glucose Monitoring Devices), by End User (Hospitals and Clinics, Ambulatory Care Centers, Home Healthcare, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The North America Vital Sign Monitoring Devices Market is anticipated to witness robust growth between 2024 and 2034, driven by an increasing prevalence of chronic diseases, rising health awareness, and the growing adoption of remote patient monitoring technologies. The ...

Global Vital Sign Monitoring Devices Market Size, Share, Trends & Analysis by Product (Pulse Oximeters, Blood Pressure Monitors, Temperature Monitoring Devices, Glucose Monitoring Devices), by End User (Hospitals and Clinics, Ambulatory Care Centers, Home Healthcare, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Global Vital Sign Monitoring Devices Market is anticipated to experience significant growth from 2024 to 2034, driven by technological advancements, increasing prevalence of chronic diseases, and the growing demand for home healthcare solutions. Valued at USD XX.XX b...

Asia Pacific Ambulance Equipment Market Size, Share, Trends & Analysis by Equipment (Transportation, Burn Care, Diagnostic and Infection Control, Blood and Hemorrhage Control, Cardiac, Respiratory Equipment), by Type (Basic Life Support Ambulance, Advanced Life Support Ambulance, Patient Transport Vehicle), by Mode of Transportation (Ground, Air, Water) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Ambulance Equipment Market is poised for substantial growth from 2024 to 2034, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and advancements in medical technology. The market is projected to reach a valuation of US...

Europe Ambulance Equipment Market Size, Share, Trends & Analysis by Equipment (Transportation, Burn Care, Diagnostic and Infection Control, Blood and Hemorrhage Control, Cardiac, Respiratory Equipment), by Type (Basic Life Support Ambulance, Advanced Life Support Ambulance, Patient Transport Vehicle), by Mode of Transportation (Ground, Air, Water) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Ambulance Equipment Market is projected to experience substantial growth over the next decade, driven by advancements in medical technology, increasing healthcare expenditure, and the rising incidence of chronic diseases and medical emergencies. The market is ...